Henan Newland Pharmaceutical Co Ltd (301277)

Currency in CNY
15.09
-0.60(-3.82%)
Delayed Data·
301277 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
301277 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.0115.44
52 wk Range
10.4119.70
Key Statistics
Bid/Ask
15.08 / 15.10
Prev. Close
15.69
Open
15.38
Day's Range
15.01-15.44
52 wk Range
10.41-19.7
Volume
14.18M
Average Volume (3m)
21.61M
1-Year Change
15.45%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
301277 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Henan Newland Pharmaceutical Co Ltd Company Profile

Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China. The company offers pharmaceutical intermediates, including L-4-hydroxyphenylglycine methyl ester, L-hydroxyphenylglycine potassium salt, L-4-hydroxyphenylglycine, and p-Toluenesulfonic acid. It also provides APIs, such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, tadalafil, chlorpheniramine maleate, clopidogrel bisulfate, lidocaine, gatifloxacin, febuxostat, esomeprazole sodium, and esomeprazole magnesium. The company was formerly known as Henan Newland Pharmaceutical Co., Ltd. and changed its name to Newland Pharmaceutical Co., Ltd. in June 2023. Newland Pharmaceutical Co., Ltd. was founded in 2005 and is based in Changge City, China.

Employees
1042
Market
China

Compare 301277 to Peers and Sector

Metrics to compare
301277
Peers
Sector
Relationship
P/E Ratio
35.3x30.5x−0.5x
PEG Ratio
14.29−0.160.00
Price/Book
3.8x3.2x2.6x
Price / LTM Sales
8.1x4.8x3.3x
Upside (Analyst Target)
-15.7%42.9%
Fair Value Upside
Unlock1.3%6.2%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.44%
Dividend Yield
2.55%
Industry Median 1.51%
Annualised payout
0.40
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 21, 2025
EPS / Forecast
0.14 / --
Revenue / Forecast
219.79M / --
EPS Revisions
Last 90 days

301277 Income Statement

FAQ

What Stock Exchange Does Henan Newland Pharmaceutical Trade On?

Henan Newland Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Henan Newland Pharmaceutical?

The stock symbol for Henan Newland Pharmaceutical is "301277."

What Is the Henan Newland Pharmaceutical Market Cap?

As of today, Henan Newland Pharmaceutical market cap is 6.15B.

What Is Henan Newland Pharmaceutical's Earnings Per Share (TTM)?

The Henan Newland Pharmaceutical EPS (TTM) is 0.44.

From a Technical Analysis Perspective, Is 301277 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Henan Newland Pharmaceutical Stock Split?

Henan Newland Pharmaceutical has split 3 times.

How Many Employees Does Henan Newland Pharmaceutical Have?

Henan Newland Pharmaceutical has 1042 employees.

What is the current trading status of Henan Newland Pharmaceutical (301277)?

As of 12 Aug 2025, Henan Newland Pharmaceutical (301277) is trading at a price of 15.09, with a previous close of 15.69. The stock has fluctuated within a day range of 15.01 to 15.44, while its 52-week range spans from 10.41 to 19.70.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.